Cipla Quality Chemicals Industries Limited (CIPLA.ug) HY2022 Interim Report

By Published On: November 9, 2021TYPE: Interim ReportsYear: 2022Period: HYCountry: UgandaSector: Pharmaceuticals

Cipla Quality Chemicals Industries Limited (CIPLA.ug) listed on the Uganda Securities Exchange under the Pharmaceuticals sector has released its 2022 interim results for the half year.

For more information about Cipla Quality Chemicals Industries Limited reports, abridged reports, interim earnings results and earnings presentations visit the Cipla Quality Chemicals Industries Limited company page on AfricanFinancials.

Indicative Share Trading Liquidity

The total indicative share trading liquidity for Cipla Quality Chemicals Industries Limited (CIPLA.ug) in the past 12 months, as of 1st November 2021, is US$48.03K (UGX174.63M). An average of US$4K (UGX14.55M) per month.

Cipla Quality Chemicals Industries Limited Interim Results for the Half Year Document

Company Profile

Cipla Quality Chemical Industries Limited is a pharmaceutical manufacturing company located in Kampala, Uganda. The company manufactures Anti-retroviral (ARVs), Artemisinin-based Combination Therapies (ACTs) and Hepatitis medicines to treat HIV/AIDS, Malaria and Hepatitis. Cipla Quality Chemicals Industries Limited is listed on the Uganda Securities Exchange

Cipla Quality Chemicals Industries Limited (CIPLA.ug)

Share price: 70.00 Shillings (0.00 | 0.00% – 16/08/22)

Sign up for Email Alerts

Recent Documents & News